Literature DB >> 12662278

Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe.

Nadia Rosencher1, Hans E M Kerkkamp, G Macheras, L M Munuera, G Menichella, David M Barton, Saskia Cremers, Ivo L Abraham.   

Abstract

BACKGROUND: The purpose of this study was to assess current practices in blood management in elective orthopedic surgery in Europe. STUDY DESIGN AND METHODS: For this 225-center prospective survey, data were collected on 3996 patients. Actual perioperative blood loss was compared to preoperative estimates. Differences in Hb levels and other outcome variables for patients receiving allogeneic versus autologous transfusions were evaluated. The probability of allogeneic transfusion based on selected predictor variables was estimated.
RESULTS: A total of 2640 (67%) hip and 1305 (33%) knee arthroplasty patients were evaluated. Estimated blood loss (median, 750 mL) was significantly lower than computed blood loss (median, 1944 mL). A total of 2762 (69%) patients received transfusions, including 1393 (35%) autologous-only and 1024 (25%) allogeneic-only. The probability of allogeneic transfusion decreased with increasing baseline Hb, but differentially so for men and women. Transfusion triggers were Hb levels of 8.93 +/- 1.83 g per dL for allogeneic transfusions, and 21 percent of these occurred when the Hb level was greater than 10 g per dL. Autologous blood transfusion was associated with a significantly lower rate (1%) of wound infections than allogeneic blood transfusion (4.2%).
CONCLUSION: Accurate assessment of preoperative Hb levels, better estimation of perioperative blood loss, efficient use of autologous blood, adherence to transfusion guidelines, and pharmacologic alternatives contribute to effective and comprehensive blood and anemia management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662278     DOI: 10.1046/j.1537-2995.2003.00348.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  128 in total

Review 1.  Transfusion of post-operative shed blood: laboratory characteristics and clinical utility.

Authors:  M Muñoz; J J García-Vallejo; M D Ruiz; R Romero; E Olalla; C Sebastián
Journal:  Eur Spine J       Date:  2004-05-08       Impact factor: 3.134

Review 2.  On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery.

Authors:  Manuel Muñoz; José Antonio García-Erce; Jorge Cuenca; Elvira Bisbe; Enrique Naveira
Journal:  Blood Transfus       Date:  2011-11-30       Impact factor: 3.443

Review 3.  Laboratory characteristics and clinical utility of post-operative cell salvage: washed or unwashed blood transfusion?

Authors:  Manuel Muñoz; Robert Slappendel; Dafydd Thomas
Journal:  Blood Transfus       Date:  2010-09-14       Impact factor: 3.443

4.  Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement.

Authors:  Jiyeol Yoon; Sungmin Kim; Soo Chan Lee; Hongsub Lim
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

5.  On the relevance of preoperative haemoglobin optimisation within a Patient Blood Management programme for elective hip arthroplasty surgery.

Authors:  Cristian Pinilla-Gracia; Jesús Mateo-Agudo; Antonio Herrera; Manuel Muñoz
Journal:  Blood Transfus       Date:  2020-04-10       Impact factor: 3.443

6.  Efficacy and economics of postoperative blood salvage in patients undergoing elective total hip replacement.

Authors:  Saqeb B Mirza; Jon Campion; John H Dixon; Sukhmeet S Panesar
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

7.  Need for preoperative anemia management clinics in Japan: initiatives at a university hospital in the USA.

Authors:  Patrick Hussey; Yoshiko Onodera; Sundara Reddy; Blain Samuelson; Sudhakar Subramani; Yatish Siddapura Ranganath; Tariq Jaradat; Satoshi Hanada
Journal:  J Anesth       Date:  2021-08-02       Impact factor: 2.078

8.  Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial.

Authors:  Johannes Cip; Mark Widemschek; Thomas Benesch; Roman Waibel; Arno Martin
Journal:  Clin Orthop Relat Res       Date:  2012-12-11       Impact factor: 4.176

Review 9.  Centers for Disease Control and Prevention 2017 Guidelines for Prevention of Surgical Site Infections: Review and Relevant Recommendations.

Authors:  K Keely Boyle; Sridhar Rachala; Scott R Nodzo
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

10.  Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland.

Authors:  Oliver M Theusinger; Stephanie L Kind; Burkhardt Seifert; Lain Borgeat; Christian Gerber; Donat R Spahn
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.